Genital Diseases, Female  >>  Esmya (ulipristal acetate)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Esmya (ulipristal acetate) / ASKA Pharma, Gedeon Richter, AbbVie, Perrigo Company
NCT00456924: Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914

Completed
2
48
Europe
VA2914
HRA Pharma
Contraception, Gynecologic Diseases
 
12/04

Download Options